chr1-196902587-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001201550.3(CFHR4):āc.228T>Cā(p.Asp76=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0115 in 1,612,242 control chromosomes in the GnomAD database, including 322 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0084 ( 22 hom., cov: 32)
Exomes š: 0.012 ( 300 hom. )
Consequence
CFHR4
NM_001201550.3 synonymous
NM_001201550.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.36
Genes affected
CFHR4 (HGNC:16979): (complement factor H related 4) This gene is a member of the complement factor H (CFH) gene family, and encodes one of the 5 CFH-related (CFHR) proteins. These 5 genes are closely linked to the CFH gene on chromosome 1q31-q32. The CFHRs are secreted plasma proteins synthesized primarily by the hepatocytes, and composed of highly-related short consensus repeats (SCRs). This protein enhances the cofactor activity of CFH, and is involved in complement regulation. It can associate with lipoproteins and may play a role in lipid metabolism. Alternatively spliced transcript variants encoding different isoforms (varying in the number of SCRs) have been described for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 1-196902587-T-C is Benign according to our data. Variant chr1-196902587-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 788946.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-196902587-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.36 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 22 AD,AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFHR4 | NM_001201550.3 | c.228T>C | p.Asp76= | synonymous_variant | 2/10 | ENST00000608469.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFHR4 | ENST00000608469.6 | c.228T>C | p.Asp76= | synonymous_variant | 2/10 | 1 | NM_001201550.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00842 AC: 1275AN: 151402Hom.: 22 Cov.: 32
GnomAD3 genomes
AF:
AC:
1275
AN:
151402
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00798 AC: 1996AN: 250044Hom.: 36 AF XY: 0.00799 AC XY: 1084AN XY: 135606
GnomAD3 exomes
AF:
AC:
1996
AN:
250044
Hom.:
AF XY:
AC XY:
1084
AN XY:
135606
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0119 AC: 17323AN: 1460728Hom.: 300 Cov.: 30 AF XY: 0.0114 AC XY: 8294AN XY: 726728
GnomAD4 exome
AF:
AC:
17323
AN:
1460728
Hom.:
Cov.:
30
AF XY:
AC XY:
8294
AN XY:
726728
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00841 AC: 1274AN: 151514Hom.: 22 Cov.: 32 AF XY: 0.00785 AC XY: 581AN XY: 74038
GnomAD4 genome
AF:
AC:
1274
AN:
151514
Hom.:
Cov.:
32
AF XY:
AC XY:
581
AN XY:
74038
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | CFHR4: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 08, 2021 | - - |
Atypical hemolytic-uremic syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Aug 26, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at